PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
      Google Scholar   
Citation:
J Clin Oncol vol 42 (10) 1114-23
Year:
2024
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
13
Parents:
3839   3895   3935  
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
Janssen Scientific Affairs, LLC  
Grants:
 
Corr. Author:
 
Authors:
                                                 
Networks:
CA043, CA136, IL018, KANSAS, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, METROMIN, MN022, NH038, NY018, TN008, TX041   
Study
AFT-19
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: